Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((hydroxymethylglutaryl-coa AND reductase AND inhibitors) OR (primary AND carcinoma AND of AND the AND liver AND cells) OR (chronic AND viral AND hepatitis)):

Hepatitis A and B Infections. Thuener J et al. Prim Care. (2017)

Hepatitis A. Matheny SC et al. Am Fam Physician. (2012)

A historical perspective on the discovery and elucidation of the hepatitis B virus. Block TM et al. Antiviral Res. (2016)

Search results

Items: 1 to 20 of 74262

1.

A Case of Rituximab-Induced Acute Thrombocytopenia in a Patient with Splenic Marginal Zone Lymphoma and Chronic Hepatitis C Virus Infection.

Qureini A, Asif S, Harry S, Madhusudhana S.

Am J Case Rep. 2019 Sep 21;20:1394-1397. doi: 10.12659/AJCR.917644.

PMID:
31541071
2.

Genetic Diversity of the Hepatitis B Virus Subgenotypes in Brazil.

Lago BV, do Espirito-Santo MP, Costa VD, Marques VA, Villar LM, Lewis-Ximenez LL, Lampe E, Mello FCA.

Viruses. 2019 Sep 15;11(9). pii: E860. doi: 10.3390/v11090860.

3.

Association of rs2111485 and rs1990760 Polymorphisms of Interferon Induced with Helicase C Domain 1 Gene with Hepatitis C Virus Clearance in Chinese Han Population.

Jiang W, Zhuo L, Wu X, Shen J, Ye X, Wang Y, Xia X, Chen H, Yu R, Yang S, Huang P.

Viral Immunol. 2019 Sep 20. doi: 10.1089/vim.2019.0109. [Epub ahead of print]

PMID:
31539314
4.

Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.

Dinesh DC, Tamilarasan S, Rajaram K, Bouřa E.

Curr Drug Targets. 2019 Sep 20. doi: 10.2174/1389450119666190920153247. [Epub ahead of print]

PMID:
31538891
6.

Statin use and the risk of colorectal cancer in a population-based electronic health records study.

Ibáñez-Sanz G, Guinó E, Pontes C, Quijada-Manuitt MÁ, de la Peña-Negro LC, Aragón M, Domínguez M, Rodríguez-Alonso L, Blasco A, García-Rodríguez A, Morros R, Moreno V.

Sci Rep. 2019 Sep 19;9(1):13560. doi: 10.1038/s41598-019-49877-5.

7.

Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.

Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA, Parise ER, Lima LMSTB, Borba LA, Evangelista AS, Rezende REF, Cheinquer H, Kuniyoshi ASO, Aires RS, Quintela EHD, Mendes LSC, Nascimento FCV, Medeiros Filho JEM, Ferraz MLCG, Abdala E, Bittencourt PL; Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment.

Ann Hepatol. 2019 Aug 30. pii: S1665-2681(19)32219-7. doi: 10.1016/j.aohep.2019.08.001. [Epub ahead of print]

8.

Hepatitis E virus infections in Europe.

Izopet J, Tremeaux P, Marion O, Migueres M, Capelli N, Chapuy-Regaud S, Mansuy JM, Abravanel F, Kamar N, Lhomme S.

J Clin Virol. 2019 Sep 8;120:20-26. doi: 10.1016/j.jcv.2019.09.004. [Epub ahead of print]

PMID:
31536936
9.

Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance.

MacLachlan JH, Romero N, Higgins N, Coutts R, Chan R, Stephens N, Cowie BC.

Aust N Z J Public Health. 2019 Sep 18. doi: 10.1111/1753-6405.12934. [Epub ahead of print]

PMID:
31535439
10.

Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.

Deterding K, Wedemeyer H.

AIDS Rev. 2019;21(3):126-134. doi: 10.24875/AIDSRev.19000080.

PMID:
31532397
11.

Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis.

Wu Z, Gong Y, Peng J, Zhang X, Tang L.

Med Sci Monit. 2019 Sep 18;25:6998-7004. doi: 10.12659/MSM.916553.

PMID:
31530794
12.

Aging with Hemophilia: The Challenge of Appropriate Drug Prescription.

Mannucci PM.

Mediterr J Hematol Infect Dis. 2019 Sep 1;11(1):e2019056. doi: 10.4084/MJHID.2019.056. eCollection 2019. Review.

13.

Chronic hepatitis delta: A state-of-the-art review and new therapies.

Gilman C, Heller T, Koh C.

World J Gastroenterol. 2019 Aug 28;25(32):4580-4597. doi: 10.3748/wjg.v25.i32.4580. Review.

14.

PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.

Senkerikova R, Frankova S, Jirsa M, Kreidlova M, Merta D, Neroldova M, Chmelova K, Spicak J, Sperl J.

PLoS One. 2019 Sep 17;14(9):e0222609. doi: 10.1371/journal.pone.0222609. eCollection 2019.

15.

Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies.

Walker MR, Leung P, Eltahla AA, Underwood A, Abayasingam A, Brasher NA, Li H, Wu BR, Maher L, Luciani F, Lloyd AR, Bull RA.

Sci Rep. 2019 Sep 16;9(1):13300. doi: 10.1038/s41598-019-49454-w.

16.

Preclinical evaluation of Amphihevir, a first-in-class clinical Hepatitis C virus NS4B inhibitor.

Tao X, Wang N, Wang J, Fu Z, Gu Z, Zhang Y, Chen S, Wang L, Yu L.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01237-19. doi: 10.1128/AAC.01237-19. [Epub ahead of print]

PMID:
31527036
17.

Targeting Hepatitis B Virus cccDNA and HBx: Recent Advances and New Approaches.

Prescott NA, Bram Y, Schwartz RE, David Y.

ACS Infect Dis. 2019 Sep 17. doi: 10.1021/acsinfecdis.9b00249. [Epub ahead of print]

PMID:
31525994
18.

Non-resectable thoracic Rosai-Dorfman disease: a case report and review of the literature.

Lin CK, Tsai YT.

World Neurosurg. 2019 Sep 13. pii: S1878-8750(19)32464-7. doi: 10.1016/j.wneu.2019.09.034. [Epub ahead of print]

PMID:
31525482
19.

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Liu K, Choi J, Le A, Yip TC, Wong VW, Chan SL, Chan HL, Nguyen MH, Lim YS, Wong GL.

Aliment Pharmacol Ther. 2019 Sep 16. doi: 10.1111/apt.15499. [Epub ahead of print]

PMID:
31524304
20.

Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.

Aguiar BF, Campos GRF, Rodrigues JPV, Marques NN, Molina BF, Bittar C, Souza FF, Martinelli ALC, Rahal P, Pereira LRL.

Clin Res Hepatol Gastroenterol. 2019 Sep 12. pii: S2210-7401(19)30181-0. doi: 10.1016/j.clinre.2019.07.015. [Epub ahead of print]

PMID:
31523019

Supplemental Content

Loading ...
Support Center